Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

BACKGROUND: Liver disease progression after Hepatitis C Virus (HCV) eradication following direct-acting antiviral (DAA) treatment in the real-life setting according to Human Immunodeficiency Virus (HIV) coinfection was evaluated. METHODS: Patients consecutively enrolled in PITER between April 2014 a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatol Int
Autors principals: Quaranta, Maria Giovanna, Ferrigno, Luigina, Monti, Monica, Filomia, Roberto, Biliotti, Elisa, Iannone, Andrea, Migliorino, Guglielmo, Coco, Barbara, Morisco, Filomena, Vinci, Maria, D’Ambrosio, Roberta, Chemello, Liliana, Massari, Marco, Ieluzzi, Donatella, Russo, Francesco Paolo, Blanc, Pierluigi, Verucchi, Gabriella, Puoti, Massimo, Rumi, Maria Grazia, Barbaro, Francesco, Santantonio, Teresa Antonia, Federico, Alessandro, Chessa, Luchino, Gentile, Ivan, Zuin, Massimo, Parruti, Giustino, Morsica, Giulia, Kondili, Loreta A.
Format: Artigo
Idioma:Inglês
Publicat: Springer India 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220859/
https://ncbi.nlm.nih.gov/pubmed/32279177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-020-10034-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars